Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL22999944

O=C(O)C(F)(F)F.O=C1CCNC(C(F)(F)F)C1

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 19/20 0.39
PNMT P11086 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23020684 0.89 PNMT (0.38) PNMT
Trifluoroacetic Acid SCHEMBL29192027 0.82 KDM1A (0.39) KDM1A
Trifluoroacetic Acid SCHEMBL26606130 0.77 SLC1A2 (0.35) KDM1A
Trifluoroacetic Acid SCHEMBL4307037 0.72 PKM (0.36) KDM1A
SCHEMBL4649924 0.70
Trifluoroacetic Acid SCHEMBL21598176 0.68 KDM1A (0.33) KDM1A
Trifluoroacetic Acid SCHEMBL27673776 0.68 CRBN (0.55) KDM1A
SCHEMBL15606429 0.67 EGLN1 (0.47)
SCHEMBL532127 0.67 EGLN1 (0.47)
SCHEMBL16967412 0.67 EGLN1 (0.47)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021032323-A1 FUSED PYRIMIDINE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF FIBROTIC DISEASES GALAPAGOS NV (BE) 2021-02-25 WO disclosed
EP-3782997-A1 FUSED PYRIMIDINE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF FIBROTIC DISEASES Galapagos N.V. (BE) 2021-02-24 EP disclosed